Davis Aaron I. - 17 Nov 2021 Form 4 Insider Report for Odonate Therapeutics, Inc.

Signature
/s/ Aaron I. Davis
Issuer symbol
N/A
Transactions as of
17 Nov 2021
Net transactions value
-$2,499,948
Form type
4
Filing time
19 Nov 2021, 18:22:38 UTC
Previous filing
21 Jun 2021
Next filing
18 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ODT Common Stock Sale $379,678 -170,000 -26% $2.23* 475,756 17 Nov 2021 Direct F1, F3
transaction ODT Common Stock Sale $1,299,240 -600,000 -11% $2.17* 5,007,086 17 Nov 2021 See footnote F2, F4
transaction ODT Common Stock Sale $487,250 -250,000 -5% $1.95* 4,757,086 18 Nov 2021 See footnote F2
transaction ODT Common Stock Sale $57,495 -30,000 -6.3% $1.92* 445,756 19 Nov 2021 Direct F1, F5
transaction ODT Common Stock Sale $276,285 -150,000 -3.2% $1.84* 4,607,086 19 Nov 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are owned directly by the reporting person. The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC ("Boxer Capital"), (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) the reporting person, and (iv) Joe Lewis (collectively, the "Boxer Group") Each member of the Boxer Group other than the reporting person disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
F2 These securities are owned directly by Boxer Capital and indirectly by the reporting person, Boxer Asset Management Inc. ("Boxer Management") and Joseph C. Lewis, by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
F3 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.97 to $2.95.
F4 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $2.0026 to $2.4018.
F5 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.84 to $1.96.